Virax Biolabs Group annual revenue
2021
2022
2023
2024
2025
2026
Virax Biolabs Group Revenue Growth & History (VRAX)
Virax Biolabs Group reported $12,423 in revenue for fiscal 2026, an increase of 96.22% from the previous fiscal year.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $12,423 | $6,092 | +96.22% |
| 2025 | 2025-03-31 | $6,331 | −$150,088 | −95.95% |
| 2024 | 2024-03-31 | $156,419 | $147,858 | +1727.11% |
| 2023 | 2023-03-31 | $8,561 | $8,561 | — |
| 2022 | 2022-03-31 | $0 | −$123,820 | −100.00% |
| 2021 | 2021-03-31 | $123,820 | — | — |
Virax Biolabs Group revenue growth trends
Over the last five reported fiscal years, revenue declined from $123,820 to $12,423, a compound annual decline of 36.86%.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Virax Biolabs Group source filings ↗